Foster Dykema Cabot & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$725K Buy
4,652
+733
+19% +$121K 0.09% 47
2023
Q2
$649K Hold
3,919
0.08% 54
2023
Q1
$607K Buy
3,919
+160
+4% +$25.8K 0.08% 50
2022
Q4
$664K Sell
3,759
-4,315
-53% -$745K 0.09% 46
2022
Q3
$1.32M Sell
8,074
-565
-7% -$95.6K 0.17% 40
2022
Q2
$1.53M Sell
8,639
-71
-0.8% -$12.7K 0.19% 35
2022
Q1
$1.54M Sell
8,710
-2,564
-23% -$436K 0.19% 40
2021
Q4
$1.93M Hold
11,274
0.22% 37
2021
Q3
$1.82M Sell
11,274
-84
-0.7% -$14.3K 0.23% 40
2021
Q2
$1.87M Sell
11,358
-577
-5% -$95.5K 0.23% 39
2021
Q1
$1.96M Buy
11,935
+1,008
+9% +$163K 0.27% 37
2020
Q4
$1.72M Sell
10,927
-1,019
-9% -$150K 0.24% 41
2020
Q3
$1.78M Hold
11,946
0.29% 33
2020
Q2
$1.68M Buy
11,946
+107
+0.9% +$15.6K 0.3% 32
2020
Q1
$1.55M Hold
11,839
0.3% 31
2019
Q4
$1.73M Sell
11,839
-3,121
-21% -$423K 0.24% 34
2019
Q3
$1.94M Sell
14,960
-1,294
-8% -$170K 0.29% 34
2019
Q2
$2.26M Sell
16,254
-145
-0.9% -$20.1K 0.34% 30
2019
Q1
$2.29M Hold
16,399
0.37% 26
2018
Q4
$2.12M Buy
16,399
+660
+4% +$92.1K 0.38% 25
2018
Q3
$2.17M Sell
15,739
-838
-5% -$111K 0.35% 26
2018
Q2
$2.19M Sell
16,577
-872
-5% -$109K 0.37% 25
2018
Q1
$2.24M Sell
17,449
-96
-0.5% -$13K 0.38% 30
2017
Q4
$2.45M Buy
17,545
+134
+0.8% +$18.7K 0.41% 29
2017
Q3
$2.26M Sell
17,411
-85
-0.5% -$11.3K 0.4% 29
2017
Q2
$2.31M Buy
17,496
+36
+0.2% +$4.59K 0.41% 30
2017
Q1
$2.17M Sell
17,460
-100
-0.6% -$11.9K 0.4% 30
2016
Q4
$2.02M Sell
17,560
-840
-5% -$97K 0.38% 34
2016
Q3
$2.17M Sell
18,400
-120
-0.6% -$14.6K 0.47% 37
2016
Q2
$2.25M Sell
18,520
-750
-4% -$85.2K 0.52% 33
2016
Q1
$2.08M Sell
19,270
-10
-0.1% -$1.03K 0.51% 31
2015
Q4
$1.98M Sell
19,280
-440
-2% -$44.2K 0.5% 30
2015
Q3
$1.84M Sell
19,720
-485
-2% -$46.9K 0.47% 31
2015
Q2
$1.97M Sell
20,205
-750
-4% -$75.1K 0.51% 31
2015
Q1
$2.11M Hold
20,955
0.52% 31
2014
Q4
$2.19M Sell
20,955
-715
-3% -$75.3K 0.52% 31
2014
Q3
$2.31M Sell
21,670
-3,570
-14% -$370K 0.56% 31
2014
Q2
$2.64M Buy
25,240
+992
+4% +$100K 0.63% 31
2014
Q1
$2.38M Buy
24,248
+150
+0.6% +$13.9K 0.59% 30
2013
Q4
$2.21M Sell
24,098
-216
-0.9% -$19.9K 0.59% 31
2013
Q3
$2.11M Sell
24,314
-260
-1% -$23.3K 0.61% 32
2013
Q2
$2.11M Buy
+24,574
New +$2.09M 0.63% 30

Other funds holding JNJ

Foster Dykema Cabot & Co's JNJ Position: Q3 2023 in Review

Foster Dykema Cabot & Co increased its Johnson & Johnson (JNJ) stake by 19% in Q3 2023, buying an estimated $121K and bringing the position to 4,652 shares worth $725K. The position accounts for 0.09% of the portfolio, ranked #47.

Foster Dykema Cabot & Co first reported a position in JNJ in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.64M in Q2 2014. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Foster Dykema Cabot & Co held 4,652 shares of Johnson & Johnson worth $725K as of Q3 2023.
  • Foster Dykema Cabot & Co bought 733 Johnson & Johnson shares in Q3 2023, an estimated $121K.
  • Johnson & Johnson made up 0.09% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #47 holding.
  • Foster Dykema Cabot & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 42 quarters since.
  • Foster Dykema Cabot & Co's Johnson & Johnson position peaked at $2.64M in Q2 2014.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.